{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T08:03:09Z","timestamp":1778400189569,"version":"3.51.4"},"reference-count":128,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.blre.2009.07.004","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T10:36:44Z","timestamp":1251369404000},"page":"257-265","source":"Crossref","is-referenced-by-count":12,"title":["The incidental monoclonal protein: Current approach to management of monoclonal gammopathy of undetermined significance (MGUS)"],"prefix":"10.1016","volume":"23","author":[{"given":"Sumit","family":"Madan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip R.","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2009.07.004_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4065\/76.5.476","article-title":"Retrospective cohort study of 148 patients with polyclonal gammopathy","volume":"76","author":"Dispenzieri","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.blre.2009.07.004_bib2","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","article-title":"Monoclonal gammopathy of undetermined significance. Natural history in 241 cases","volume":"64","author":"Kyle","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2009.07.004_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.blre.2009.07.004_bib4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies. Multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.07.004_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.blre.2007.01.002","article-title":"Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"21","author":"Rajkumar","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2009.07.004_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4065\/81.5.693","article-title":"Monoclonal gammopathy of undetermined significance, Waldenstrom macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment","volume":"81","author":"Rajkumar","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.blre.2009.07.004_bib7","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.blre.2009.07.004_bib8","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"New Engl J Med"},{"key":"10.1016\/j.blre.2009.07.004_bib9","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0025-6196(11)61090-2","article-title":"Prevalence of monoclonal gammopathy of undetermined significance. study of 52, 802 persons in Nagasaki City, Japan","volume":"82","author":"Iwanaga","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.blre.2009.07.004_bib10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood.V40.5.719.719","article-title":"Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma","volume":"40","author":"Kyle","year":"1972","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jcp.35.1.63","article-title":"Monoclonal gammopathies in the adult population of Finistere, France","volume":"35","author":"Saleun","year":"1982","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.blre.2009.07.004_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.0954-6820.1966.tb05453.x","article-title":"Frequency of pathological proteins (M-components) om 6, 995 sera from an adult population","volume":"179","author":"Axelsson","year":"1966","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.blre.2009.07.004_bib13","first-page":"377","article-title":"Monoclonal gammopathies of undetermined significance. Clinical course and biological aspects of 397 cases","volume":"36","author":"Giraldo","year":"1991","journal-title":"Sangre (Barc)"},{"key":"10.1016\/j.blre.2009.07.004_bib14","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9343(98)00080-1","article-title":"Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly","volume":"104","author":"Cohen","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2009.07.004_bib16","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0025-6196(11)61086-0","article-title":"Monoclonal gammopathy of undetermined significance. genetic vs. environmental etiologies","volume":"82","author":"Munshi","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.blre.2009.07.004_bib17","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMcp052790","article-title":"Clinical practice. Monoclonal gammopathy of undetermined significance","volume":"355","author":"Blade","year":"2006","journal-title":"New Engl J Med"},{"key":"10.1016\/j.blre.2009.07.004_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.hoc.2007.08.005","article-title":"Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"21","author":"Kyle","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.blre.2009.07.004_bib19","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0025-6196(11)61089-6","article-title":"Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana","volume":"82","author":"Landgren","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.blre.2009.07.004_bib20","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2385::AID-CNCR13>3.0.CO;2-A","article-title":"Multiple myeloma and family history of cancer among blacks and whites in the US","volume":"85","author":"Brown","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2009.07.004_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00051914","article-title":"Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study","volume":"3","author":"Eriksson","year":"1992","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.blre.2009.07.004_bib22","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1002\/ijc.21745","article-title":"Familial characteristics of autoimmune and hematologic disorders in 8, 406 multiple myeloma patients: a population-based case-control study","volume":"118","author":"Landgren","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2009.07.004_bib23","first-page":"66","article-title":"Familiarity of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families","volume":"90","author":"Ogmundsdottir","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2009.07.004_bib24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood-2008-12-192575","article-title":"Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance","volume":"114","author":"Vachon","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib25","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","article-title":"Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/17.3.512","article-title":"Family history of autoimmune disorders and cancer in multiple myeloma","volume":"17","author":"Linet","year":"1988","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.blre.2009.07.004_bib27","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/1097-0142(19930201)71:3<745::AID-CNCR2820710316>3.0.CO;2-1","article-title":"Pernicious anemia and subsequent cancer. A population-based cohort study","volume":"71","author":"Hsing","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2009.07.004_bib28","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/bjc.1989.169","article-title":"Cancer risk following pernicious anaemia","volume":"59","author":"Brinton","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2009.07.004_bib29","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1182\/blood-2009-02-203471","article-title":"Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib30","series-title":"Myeloma: Biology and Management","first-page":"35","article-title":"The molecular biology of multiple myeloma","author":"Bergsagel","year":"2004"},{"key":"10.1016\/j.blre.2009.07.004_bib31","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","article-title":"Genetics and cytogenetics of multiple myeloma: a workshop report","volume":"64","author":"Fonseca","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2009.07.004_bib32","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/leu.2008.203","article-title":"Pathogenesis and progression of monoclonal gammopathy of undetermined significance","volume":"22","author":"Blade","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2009.07.004_bib33","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.1158\/1078-0432.CCR-07-0031","article-title":"Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients","volume":"13","author":"Brousseau","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.blre.2009.07.004_bib34","first-page":"5640","article-title":"High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies","volume":"58","author":"Avet-Loiseau","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2009.07.004_bib35","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood.V90.2.526","article-title":"The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization","volume":"90","author":"Nishida","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib36","first-page":"4546","article-title":"14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myelome","volume":"59","author":"Avet-Loiseau","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2009.07.004_bib37","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","article-title":"Genomic abnormalities in monoclonal gammopathy of undetermined significance","volume":"100","author":"Fonseca","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib38","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2005-02-0761","article-title":"A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS","volume":"106","author":"Chng","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib39","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/sj.leu.2401909","article-title":"Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance","volume":"14","author":"Konigsberg","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2009.07.004_bib40","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1365-2141.1998.01124.x","article-title":"Absence of p53 deletions in bone marrow plasma cells of patients with monoclonal gammopathy of undetermined significance","volume":"103","author":"Ackermann","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.07.004_bib41","first-page":"758","article-title":"Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias","volume":"8","author":"Corradini","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2009.07.004_bib42","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V92.3.802","article-title":"Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy","volume":"92","author":"Drach","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib43","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1182\/blood.V81.10.2658.2658","article-title":"Phenotypic difference of normal plasma cells from mature myeloma cells","volume":"81","author":"Harada","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib44","first-page":"1655","article-title":"Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma","volume":"152","author":"Ocqueteau","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.blre.2009.07.004_bib45","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/sj.leu.2403823","article-title":"CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations","volume":"19","author":"Kumar","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2009.07.004_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/10428199509054750","article-title":"Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies","volume":"20","author":"Vacca","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2009.07.004_bib47","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","article-title":"Bone marrow angiogenesis and progression in multiple myeloma","volume":"87","author":"Vacca","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.07.004_bib48","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","article-title":"Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes","volume":"96","author":"Aguayo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib49","first-page":"2210","article-title":"Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis","volume":"8","author":"Rajkumar","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.blre.2009.07.004_bib50","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood-2003-11-3811","article-title":"Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression","volume":"104","author":"Kumar","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib51","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.V93.9.3064","article-title":"Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma","volume":"93","author":"Vacca","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib52","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1038\/sj.leu.2403970","article-title":"Growth factors and antiapoptotic signaling pathways in multiple myeloma","volume":"19","author":"van de Donk","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2009.07.004_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/332083a0","article-title":"Autocrine generation and requirement of BSF-2\/IL-6 for human multiple myelomas","volume":"332","author":"Kawano","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.blre.2009.07.004_bib54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0145-2126(95)00085-2","article-title":"Therapeutic strategies for inhibition of interleukin-6 mediated multiple myeloma cell growth","volume":"20","author":"Ogata","year":"1996","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2009.07.004_bib55","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1182\/blood.V96.12.3880","article-title":"The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells","volume":"96","author":"Rawstron","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib56","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0889-8588(05)70115-5","article-title":"The role of interleukin-1 beta in the pathogenesis of multiple myeloma","volume":"13","author":"Lust","year":"1999","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.blre.2009.07.004_bib57","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1038\/sj.onc.1204623","article-title":"The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications","volume":"20","author":"Hideshima","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2009.07.004_bib58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","article-title":"Multiple myeloma: evolving genetic events and host interactions","volume":"2","author":"Kuehl","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.blre.2009.07.004_bib59","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1182\/blood-2006-03-009910","article-title":"Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation","volume":"108","author":"Hanamura","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib60","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/blood.V88.7.2699.bloodjournal8872699","article-title":"Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial","volume":"88","author":"Liu","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib61","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/humu.1177","article-title":"High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis","volume":"18","author":"Bezieau","year":"2001","journal-title":"Hum Mutat"},{"key":"10.1016\/j.blre.2009.07.004_bib62","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood.V81.10.2708.2708","article-title":"Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias","volume":"81","author":"Corradini","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib63","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.1992.tb08245.x","article-title":"Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance","volume":"81","author":"Blade","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.07.004_bib64","first-page":"1172","article-title":"The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance","volume":"86","author":"Gregersen","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2009.07.004_bib65","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.20.6.1625","article-title":"Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"20","author":"Cesana","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2009.07.004_bib66","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4065\/82.4.428","article-title":"Monoclonal gammopathy of undetermined significance. predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size","volume":"82","author":"Rosinol","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.blre.2009.07.004_bib67","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1182\/blood.V87.3.912.bloodjournal873912","article-title":"Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy","volume":"87","author":"Baldini","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib68","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4065\/79.7.859","article-title":"Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance. the original Mayo Clinic series 25 years later","volume":"79","author":"Kyle","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.blre.2009.07.004_bib69","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0025-6196(12)60015-9","article-title":"\u201cBenign\u201d monoclonal gammopathy \u2013 after 20 to 35 years of follow-up","volume":"68","author":"Kyle","year":"1993","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.blre.2009.07.004_bib70","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2141.2004.05169.x","article-title":"Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance","volume":"127","author":"Rajkumar","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.07.004_bib71","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib72","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.blre.2009.07.004_bib73","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1182\/blood.V88.5.1780.1780","article-title":"Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma","volume":"88","author":"Witzig","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib74","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1200\/JCO.2005.03.159","article-title":"Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance","volume":"23","author":"Kumar","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2009.07.004_bib75","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/jama.1984.03340380031018","article-title":"\u2018Benign\u2019 monoclonal gammopathy. A misnomer?","volume":"251","author":"Kyle","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2009.07.004_bib76","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJM200206273462614","article-title":"Monoclonal gammopathy of undetermined significance","volume":"346","author":"Montoto","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.blre.2009.07.004_bib77","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4065\/79.7.855","article-title":"On the \u201csignificance\u201d of monoclonal gammopathy of undetermined significance","volume":"79","author":"Blade","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.blre.2009.07.004_bib78","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1182\/blood-2003-02-0380","article-title":"Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index","volume":"102","author":"Terpos","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib79","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2141.2004.05092.x","article-title":"Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS)","volume":"126","author":"Politou","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.07.004_bib80","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/107327489800500301","article-title":"Biology of the transition of monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma","volume":"5","author":"Lust","year":"1998","journal-title":"Cancer Control"},{"key":"10.1016\/j.blre.2009.07.004_bib81","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/asheducation-2005.1.340","article-title":"MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management hematology","author":"Rajkumar","year":"2005","journal-title":"Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2009.07.004_bib82","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1182\/blood.V90.9.3743","article-title":"Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance. quantification by urinary pyridinium cross-links of collagen","volume":"90","author":"Pecherstorfer","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib83","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0609.1997.tb00932.x","article-title":"Abnormal bone turnover in monoclonal gammopathy of undetermined significance. analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens","volume":"58","author":"Vejlgaard","year":"1997","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2009.07.004_bib84","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2141.2006.06269.x","article-title":"Fracture risk in patients with monoclonal gammopathy of undetermined significance","volume":"135","author":"Gregersen","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.07.004_bib85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1034\/j.1600-0609.2002.00505.x","article-title":"Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma","volume":"69","author":"Jakob","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2009.07.004_bib86","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/sj.thj.6200564","article-title":"Bone remodelation markers are useful in the management of monoclonal gammopathies","volume":"5","author":"Hernandez","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.blre.2009.07.004_bib87","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF02230356","article-title":"Bone remodelling in monoclonal gammopathies of uncertain significance, symptomatic and nonsymptomatic myeloma","volume":"15","author":"Laroche","year":"1996","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.blre.2009.07.004_bib88","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1445-5994.2001.00055.x","article-title":"Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance","volume":"31","author":"Diamond","year":"2001","journal-title":"Intern Med J"},{"key":"10.1016\/j.blre.2009.07.004_bib89","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1359\/jbmr.0301212","article-title":"Fracture risk in monoclonal gammopathy of undetermined significance","volume":"19","author":"Melton","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.blre.2009.07.004_bib90","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2141.2006.06217.x","article-title":"Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance","volume":"134","author":"Pepe","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.07.004_bib91","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000162282","article-title":"Prevalence of monoclonal gammopathy of undetermined significance\/myeloma in patients with acute osteoporotic vertebral fractures","volume":"120","author":"Golombick","year":"2008","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2009.07.004_bib92","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1359\/JBMR.050317","article-title":"Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study","volume":"20","author":"Pongchaiyakul","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.blre.2009.07.004_bib93","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00223-008-9145-2","article-title":"The effects of alendronate treatment in osteoporotic patients affected by monoclonal gammopathy of undetermined significance","volume":"82","author":"Pepe","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.blre.2009.07.004_bib94","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1158\/1078-0432.CCR-08-0666","article-title":"Zoledronic acid markedly improves bone mineral density for patients with monoclonal gammopathy of undetermined significance and bone loss","volume":"14","author":"Berenson","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.blre.2009.07.004_bib95","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.blre.2009.07.004_bib96","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood-2008-04-151076","article-title":"Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma","volume":"112","author":"Kristinsson","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib97","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/cncr.20405","article-title":"Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease","volume":"101","author":"Srkalovic","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2009.07.004_bib98","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/annonc\/mdh385","article-title":"The risk of venous thromboembolic disease in patients with monoclonal gammopathy of undetermined significance","volume":"15","author":"Sallah","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.blre.2009.07.004_bib99","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3816\/CLM.2007.n.027","article-title":"Prothrombotic coagulation abnormalities in patients with paraprotein-producing B-cell disorders","volume":"7","author":"Auwerda","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.blre.2009.07.004_bib100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.blre.2007.07.004","article-title":"POEMS syndrome","volume":"21","author":"Dispenzieri","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2009.07.004_bib101","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib102","first-page":"153","article-title":"Studies on a unique diagnostic serum globulin in papular mucinosis (lichen myxedematosus)","volume":"2","author":"James","year":"1967","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.blre.2009.07.004_bib103","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2133.1983.tb03553.x","article-title":"Discoid lupus erythematosus and monoclonal gammopathy","volume":"109","author":"Powell","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.blre.2009.07.004_bib104","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","article-title":"Monoclonal gammopathy of undetermined significance","volume":"134","author":"Kyle","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.07.004_bib105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-4362.2003.01565.x","article-title":"Scleromyxedema revisited","volume":"42","author":"Pomann","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.blre.2009.07.004_bib106","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00561120","article-title":"Paraproteinaemia in erythema elevatum diutinum","volume":"260","author":"Kovary","year":"1977","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.blre.2009.07.004_bib107","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-4632.2002.1432_4.x","article-title":"Erythema elevatum diutinum and IgA paraproteinaemia: \u2018a preclinical iceberg\u2019","volume":"41","author":"Chowdhury","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.blre.2009.07.004_bib108","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1182\/blood.V91.9.3518","article-title":"Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation","volume":"91","author":"Zent","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.07.004_bib109","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/lt.500020508","article-title":"Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder","volume":"2","author":"Badley","year":"1996","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.blre.2009.07.004_bib110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.410300111","article-title":"Neuropathy associated with monoclonal gammopathies of undetermined significance","volume":"30","author":"Gosselin","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.blre.2009.07.004_bib111","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.ajkd.2005.05.004","article-title":"Focal and segmental glomerulosclerosis and plasma cell proliferative disorders","volume":"46","author":"Dingli","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.blre.2009.07.004_bib112","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ki.2008.577","article-title":"Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits","volume":"75","author":"Czarnecki","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.blre.2009.07.004_bib113","first-page":"632","article-title":"Fibrillary (immunotactoid) glomerulopathy","volume":"15","author":"Esparza","year":"1991","journal-title":"A possible role for kappa light chain in its etiology and\/or pathogenesis. Am J Surg Pathol"},{"key":"10.1016\/j.blre.2009.07.004_bib114","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0272-6386(12)80775-X","article-title":"Monoclonal gammopathy and glomerulonephritis with organized microtubular deposits","volume":"15","author":"Rollino","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.blre.2009.07.004_bib115","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2002.05668.x","article-title":"Role of Helicobacter pylori infection in the incidence and clinical course of monoclonal gammopathy of undetermined significance","volume":"97","author":"Malik","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.blre.2009.07.004_bib116","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1046\/j.1365-2141.2002.03912.x","article-title":"Helicobacter pylori infection and monoclonal gammopathy of undetermined significance","volume":"119","author":"Rajkumar","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.07.004_bib117","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archinte.1975.00330010064009","article-title":"Monoclonal gammopathy in lymphoma","volume":"135","author":"Alexanian","year":"1975","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.blre.2009.07.004_bib118","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0025-6196(12)65225-2","article-title":"The spectrum of IgM monoclonal gammopathy in 430 cases","volume":"62","author":"Kyle","year":"1987","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.blre.2009.07.004_bib119","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ajcp\/87.3.385","article-title":"Monoclonal proteins in chronic lymphocytic leukemia","volume":"87","author":"Noel","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2009.07.004_bib120","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/art.1780120603","article-title":"Rheumatoid arthritis, dysproteinemic arthropathy, and paraproteinemia","volume":"12","author":"Zawadzki","year":"1969","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.blre.2009.07.004_bib121","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/ard.51.8.951","article-title":"Ankylosing spondylitis and monoclonal gammopathies","volume":"51","author":"Renier","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.blre.2009.07.004_bib122","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/ard.44.7.501","article-title":"IgG monoclonal gammopathy in four patients with polymyalgia rheumatica","volume":"44","author":"Ilfeld","year":"1985","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.blre.2009.07.004_bib123","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/096120339200100410","article-title":"Monoclonal gammopathy in systemic lupus erythematosus","volume":"1","author":"Porcel","year":"1992","journal-title":"Lupus"},{"issue":"Suppl. 13","key":"10.1016\/j.blre.2009.07.004_bib124","first-page":"S45","article-title":"Et al. HCV and monoclonal gammopathies","volume":"13","author":"Mussini","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.blre.2009.07.004_bib125","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0002-9343(87)90659-0","article-title":"Recurrent febrile panniculitis and hepatitis in two patients with acquired complement deficiency and paraproteinemia","volume":"83","author":"Pascual","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2009.07.004_bib126","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0002-9343(92)90749-2","article-title":"Control of systemic capillary leak syndrome with aminophylline and terbutaline","volume":"92","author":"Droder","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2009.07.004_bib127","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1297-319X(01)00343-8","article-title":"Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand\u2019s syndrome. Seven new cases with a literature review","volume":"69","author":"Lamboley","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.blre.2009.07.004_bib128","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9343(02)01124-5","article-title":"Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2","volume":"113","author":"Fremeaux-Bacchi","year":"2002","journal-title":"Am J Med"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X09000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X09000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T20:17:25Z","timestamp":1590092245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X09000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":128,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0268960X09000423"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2009.07.004","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}